Publications by authors named "Renata D'Inca"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

78,449

Total Likes

1,960

Extended Reach

85,890

Social Features

10
M
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease.
Sonia Facchin, Nicola Vitulo, Matteo Calgaro, Andrea Buda, Chiara Romualdi, Daniel Pohl, Barbara Perini, Greta Lorenzon, Carla Marinelli, Renata D'Incà

Neurogastroenterol Motil· October 2020

Videos about Article: user user user 1

4 2 6 2 4

View All Article and Social Media Activity
L
Long-term Disease Course of Crohn's Disease in a Prospective European Population-based Inception Cohort: An Epi-IBD Cohort Study.
Mads Damsgaard Wewer, Søren Lophaven, Peter L Lakatos, Lorant Gonczi, Riina Salupere, Renata D'Inca

Clin Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence, satisfaction, and quality of life in Wilson disease patients after switching to trientine tetrahydrochloride: observational data from a dual cohort study.
Valentina Medici, Nora Cazzagon, Pier M Battezzati, Andrea Crosignani, Alberto Civolani

Front Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term disease course of ulcerative colitis in a prospective European population-based inception cohort-an Epi-IBD cohort study.
Mads Damsgaard Wewer, Søren Lophaven, Peter L Lakatos, Lorant Gonczi, Riina Salupere, Renata D'Inca

J Crohns Colitis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary prostaglandin metabolites evaluation for activity monitoring in inflammatory bowel disease.
Renata d'Inca, Hana Manceau, Lucia Zanni, Laura Vernoux, Xavier Treton

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral administration of DG® after ileostomy closure in restorative proctocolectomy: a randomized placebo-controlled trial (microbiota and immune microenvironment in pouchitis -MEP1).
Imerio Angriman, Melania Scarpa, Edoardo Savarino, Ilaria Patuzzi, Alessandra Rigo

Gut Microbes· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD).
Gaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, Marco Astegiano, Walter Fries

Dig Liver Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets.
Peter Ott, Thomas Sandahl, Aftab Ala, David Cassiman, Eduardo Couchonnal-Bedoya, Renata D'Inca

JHEP Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal cancer and inflammatory bowel diseases share common salivary proteomic pathways.
Nicole Contran, Giorgio Arrigoni, Ilaria Battisti, Renata D'Incà, Imerio Angriman

Sci Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leaving behind a diseased small bowel during surgery for Crohn's disease: Long-term outcomes.
Imerio Angriman, Silvia Degasperi, Claudia Mescoli, Carmelo Lacognata, Claudia Armellin

Surg Today· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate Immunity Activation in Newly Diagnosed Ileocolonic Crohn's Disease: A Cohort Study.
Imerio Angriman, Giovanni Bordignon, Andromachi Kotsafti, Claudia Mescoli, Melania Scarpa

Dis Colon Rectum· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy in elderly IBD patients.
Fabiana Castiglione, Nicola Imperatore, Fabiana Zingone, Renata D'Incà

Minerva Gastroenterol (Torino)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in IBD: What to Utilize for the Diagnosis?
Renata D'Incà, Giulia Sturniolo

Diagnostics (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission.
Johan Burisch, Mirabella Zhao, Selwyn Odes, Peter De Cruz, Severine Vermeire, Renata D'Inca

Lancet Gastroenterol Hepatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease.
Marco Vincenzo Lenti, Maria Lia Scribano, Livia Biancone, Rachele Ciccocioppo, Daniela Pugliese

Front Med (Lausanne)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study.
Gaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, Marco Astegiano, Walter Fries

Inflamm Bowel Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of ER Stress Mediated Unfolded Protein Responses and ER Stress Inhibitors in the Pathogenesis of Inflammatory Bowel Disease.
Dikshita Deka, Renata D'Incà, Giacomo Carlo Sturniolo, Alakesh Das, Surajit Pathak

Dig Dis Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Michael L Schilsky, Anna Czlonkowska, Massimo Zuin, David Cassiman, Carlos Twardowschy, Renata D'Inca

Lancet Gastroenterol Hepatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study.
Carla Marinelli, Fabiana Zingone, Maria Giovanna Lupo, Raffaella Marin, Renata D'Incà

J Clin Gastroenterol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Padova Prognostic Score for Colitis in Predicting Long-Term Outcome After Restorative Proctocolectomy.
Imerio Angriman, Annaclaudia Colangelo, Claudia Mescoli, Matteo Fassan, Renata D'Incà

Front Surg· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy.
Alessandro Vitello, Mauro Grova, Daniela Pugliese, Fernando Rizzello, Francesco Lanzarotto

Dig Liver Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Female reproductive health and inflammatory bowel disease: A practice-based review.

Dig Liver Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident Colorectal Cancer in Inflammatory Bowel Disease.
Benedetto Neri, Maria Lia Scribano, Alessandro Armuzzi, Fabiana Castiglione, Renata D'Incà

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study.
Davide Massimi, Brigida Barberio, Lorenzo Bertani, Francesco Costa, Antonio Ferronato

Therap Adv Gastroenterol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator.
Linda Cingolani, Brigida Barberio, Fabiana Zingone, Antonio Ferronato, Lorenzo Bertani

Sci Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn's disease and control subjects with no inflammatory bowel disease.
Flavia Merigo, Alessandro Brandolese, Sonia Facchin, Federico Boschi, Marzia Di Chio

Cell Tissue Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis